$MZTI

Pigott, Thomas K. purchased $98K of MZTI

Pigott, Thomas K. (VP, CFO and Asst. Secretary) purchased 900 shares of MARZETTI CO (MZTI) at $109.01 on 2026-06-10.

Original reporting
SEC EDGAR · Pigott, Thomas K.
Published Jun 12, 2026, 2:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 12, 2026, 2:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MZTI
Bullish
medium confidence
Mentioned
$MZTI
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MZTIBullishLow
01

Why it matters

The only new fact is the officer’s open-market purchase details; it does not include earnings, guidance, contracts, litigation, or regulatory actions.

02

Market read

Traders may note mild sentiment support from officer buying, but there is no fundamental catalyst to drive a sustained repricing.

03

What to watch

No 10b5-1 plan is cited, but the article also provides no context on prior trading patterns, option exercises, or whether the purchase was part of a recurring personal strategy.

Relevance 4/10Novelty 2/10Timing: SEC Form 4 filed 2026-06-12 (transaction dated 2026-06-10).

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Marzetti Co (MZTI).

Company-level read

Ticker impact

$MZTIBullishMedium confidence
Context

SEC Form 4 shows CFO Thomas K. Pigott bought 900 shares of Marzetti Co at $109.01 on 2026-06-10 (direct open-market purchase).

Expected impact

Likely limited near-term impact; any effect is more sentiment/positioning than fundamentals.

Evidence & confidence

The filing is primary-source and the buyer is a named officer (CFO), but the transaction value (~$98k) is modest versus typical market-moving thresholds and provides no new company guidance or events.

Market effects

No clear sector read-through; this is a single-company insider transaction with no disclosed business change.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine (e.g., compensation-related liquidity needs) and may not signal a change in fundamentals.

Key entities

  • MARZETTI CO

    Company whose insider transaction is disclosed on Form 4.

  • Thomas K. Pigott

    VP, CFO and Asst. Secretary who purchased 900 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MZTIHigh

Marzetti’s (MZTI) Record Streak Hits a Wall With Outbreak and Guidance Cut

Marzetti (MZTI) reported a 2.2% sales decline to $465.0M in Q4, but adjusted sales grew. Fiscal 2026 saw record net sales, gross profit, and operating income. Gross margin expanded 220 bps to 24.5%. A Cyclospora outbreak may cut Q1 sales by 250 bps, leading to a 15% drop in operating income. The company acquired Bachan's, which added $15.4M in sales.

Med

Marzetti (MZTI) Q4 2026 Earnings Call Transcript

Marzetti (MZTI) reported Q4 2026 net sales of $465M, down 2.2% YoY. Adjusted net sales rose 0.4%, driven by a 0.9% increase in retail sales, including $15.4M from Bachan's. Gross profit and operating income reached record highs, up 7.4% and 48.2% respectively. The company also reported record annual operating cash flow of $283.8M. The company increased its dividend by 5% and completed $36.3M in share buybacks.

$MZTIMedAI 8/10

The Dividend King Investors May Have Overlooked

The Marzetti Company (MZTI) has increased its dividend for 63 consecutive years, with the latest quarterly dividend at $1.00 per share. Fiscal 2026 saw record operating cash flow of $283.8 million, with dividends consuming 38% of it. Net income rose to $191.6 million, and gross margin expanded to 24.5%. The company rebranded in 2025, aligning with its food brands.

$MZTIMed

MZTI Q2 Deep Dive: Margin Expansion and New Product Launches Offset Sales Decline

The Marzetti Company (MZTI) reported Q2 CY2026 sales of $465M, down 2.2% YoY, missing expectations. Non-GAAP EPS of $1.46 beat estimates by 4.1%. Management cited lower sales volumes and the exit of a supply agreement for the decline, but attributed higher margins to productivity initiatives and the Bachan’s acquisition. The company expects growth from Bachan’s integration, new products, and pricing actions.

$MZTIMedAI 8/10

The Marzetti Co (MZTI) (Q4 2026) Earnings Call Highlights: Record Year Fueled

The Marzetti Co (MZTI) reported a 2.2% decline in Q4 net sales due to reduced club channel sales and pipeline build comparisons. A Cyclospora outbreak is expected to cause a 250 basis point net sales headwind in Q1 2027. Core retail business, excluding Bachan's, saw a 7% organic volume decline. Commodity inflation is forecasted at 5% for fiscal 2027. The company expects 100 basis points of gross margin growth in fiscal 2027, driven by Bachan's integration and cost savings. CEO Dave Ciesinski ant